Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults
- 18 August 2005
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 103 (2), 156-163
- https://doi.org/10.1016/j.ijcard.2004.08.050
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Response to nitric oxide during adult cardiac surgery.Journal of Investigative Surgery, 2002
- Dose response to nitric oxide in adult cardiac surgery patientsJournal of Clinical Anesthesia, 2001
- Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgeryPerfusion, 1999
- Effects of Dipyridamole and Inhaled Nitric Oxide in Pediatric Patients with Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Effective control of refractory pulmonary hypertension after cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.JCI Insight, 1996
- The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.American Journal of Respiratory and Critical Care Medicine, 1995
- Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary HypertensionThe New England Journal of Medicine, 1995
- Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambsJournal of Applied Physiology, 1995
- Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics.Circulation, 1993